Progenics Pharmaceuticals, Inc. (OQ:PGNX)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for PGNX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET September 17th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Sep 11/19 Sep 9/19 Velan Capital, L.P. Direct Ownership Common Stock, $0.0013 par value P - Open market or private purchase 72,023 $4.99
Sep 9/19 Sep 9/19 LTE Partners, LLC Direct Ownership Common Stock, $0.0013 par value P - Open market or private purchase 21,480 $4.94
Sep 9/19 Sep 5/19 LTE Partners, LLC Direct Ownership Common Stock, $0.0013 par value P - Open market or private purchase 43,520 $4.62
Sep 5/19 Sep 4/19 Velan Capital, L.P. Direct Ownership Common Stock, $0.0013 par value P - Open market or private purchase 243,614 $4.51
Sep 5/19 Sep 3/19 Velan Capital, L.P. Direct Ownership Common Stock, $0.0013 par value P - Open market or private purchase 277,424 $4.39
Aug 27/19 Aug 27/19 Velan Capital, L.P. Direct Ownership Common Stock, $0.0013 par value Form 3 : Initial Statement of Beneficial Ownership of Securities    
Aug 27/19 Aug 27/19 Nohria Virinder Direct Ownership Common Stock, $0.0013 par value Form 3 : Initial Statement of Beneficial Ownership of Securities    
Aug 27/19 Aug 27/19 LTE Partners, LLC Direct Ownership Common Stock, $0.0013 par value Form 3 : Initial Statement of Beneficial Ownership of Securities    
Aug 27/19 Aug 27/19 Sarpangal Deepak Direct Ownership Common Stock, $0.0013 par value Form 3 : Initial Statement of Beneficial Ownership of Securities    
Aug 27/19 Aug 27/19 Cooke Terence Direct Ownership Common Stock, $0.0013 par value Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for PGNX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET September 17th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Sep 11/19 Sep 9/19 Velan Capital, L.P. Direct Ownership Common Stock, $0.0013 par value P - Open market or private purchase 72,023 $4.99
Sep 9/19 Sep 9/19 LTE Partners, LLC Direct Ownership Common Stock, $0.0013 par value P - Open market or private purchase 21,480 $4.94
Sep 9/19 Sep 5/19 LTE Partners, LLC Direct Ownership Common Stock, $0.0013 par value P - Open market or private purchase 43,520 $4.62
Sep 5/19 Sep 4/19 Velan Capital, L.P. Direct Ownership Common Stock, $0.0013 par value P - Open market or private purchase 243,614 $4.51
Sep 5/19 Sep 3/19 Velan Capital, L.P. Direct Ownership Common Stock, $0.0013 par value P - Open market or private purchase 277,424 $4.39
Aug 27/19 Aug 26/19 Velan Capital, L.P. Direct Ownership Common Stock, $0.0013 par value P - Open market or private purchase 73,230 $4.30
Aug 27/19 Aug 23/19 Velan Capital, L.P. Direct Ownership Common Stock, $0.0013 par value P - Open market or private purchase 130,826 $4.31
Aug 27/19 Aug 27/19 Velan Capital, L.P. Direct Ownership Common Stock, $0.0013 par value Form 3 : Initial Statement of Beneficial Ownership of Securities    
Aug 27/19 Aug 27/19 Nohria Virinder Direct Ownership Common Stock, $0.0013 par value Form 3 : Initial Statement of Beneficial Ownership of Securities    
Aug 27/19 Aug 27/19 LTE Partners, LLC Direct Ownership Common Stock, $0.0013 par value Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $PGNX

StockTwits